(Q40432870)

20 September 2017

title

Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma (English)

1 reference

20 September 2017

0 references

0 references

Bifidobacterium infantis

object named as

Bifidobacterium infantis

1 reference

Cheng Yi

1

1 reference

20 September 2017

Ying Huang

series ordinal

2

1 reference

20 September 2017

Zhi-ying Guo

series ordinal

3

1 reference

20 September 2017

Shu-ren Wang

series ordinal

4

1 reference

20 September 2017

publication date

1 May 2005

1 reference

Acta Pharmacologica Sinica

20 September 2017

published in

1 reference

20 September 2017

volume

26

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

629-634

1 reference

Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitro

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00094.X

Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00094.X

Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00094.X

Prodrug strategies in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00094.X

Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00094.X

Clostridium spores for tumor-specific drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00094.X

Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00094.X

Are hepatomas a good target for suicide gene therapy? An experimental study in rats using retroviral-mediated transfer of thymidine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00094.X

Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00094.X

Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00094.X

Quantitative comparison of lactose and glucose utilization in Bifidobacterium longum cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00094.X

In vivo safety assessment of two Bifidobacterium longum strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00094.X

10.1111/J.1745-7254.2005.00094.X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1015201909

0 references

1 reference